Regulation & Compliance
Knowing and understanding the impact of research compliance and regulation.
Top Resources for Regulation & Compliance
Financial Conflicts of Interest in Research Program
Disclosing Support to Federal Agencies for International Partners
Topics:
Philadelphia Symposium on Research Credibility and Excellence 2018
Hosting Foreign Visitors | for International Partners
Tips on compliance management when hosting foreign visitors.
Topics:
International Travel Guidance
International travel guidance provided by Penn Global.
Topics:
Frequently Asked Questions
As part of a collaboration effort with a colleague at a foreign institution, we are submitting a joint application for funding to a foreign entity. Does this need to be disclosed in my federal grant applications?
Please consult with the Office of Research Services regarding the internal approval process. In addition, you must disclose all such applications in your “Current and Pending” or “Other Support” page.
How does the Reminders of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and Foreign Components (NOT-OD-19-114) impact the FCOI policy?
There has been no change to the FCOI policy. Investigators are still required to disclose to their significant financial interests to their institution. This includes financial interests received from a foreign institution of higher education or the government of another country. This requirement is distinct from other support and foreign components.
The addition a new foreign component requires prior NIH approval.
What if NIH determines that an institution is not complying with NIH policies for transparency and disclosure of all Other Support?
NIH takes the issue of protecting the integrity of U.S. biomedical research seriously. If noncompliance is identified, potential action by NIH may include withdrawing approval of the Program Director/Principal Investigator or other researchers contributing to the NIH award, imposing specific award conditions, disallowing costs, withholding future awards including the possibility of suspending or terminating the award, per NIH Grants Policy Statement, Section 8.5.